Acitretin Alternatives Compared
Acitretin | Apremilast | Clobetasol topical |
|
---|
Acitretin | Apremilast | Clobetasol topical |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Psoriasis, Psoriatic Arthritis, Pityriasis rubra pilaris. Acitretin may also be used for purposes not listed in this medication guide. |
Prescription only
Apremilast is a PDE4 inhibitor that may be used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet’s Disease. It has been associated with severe diarrhea, nausea, a... View more |
Prescription only
Prescribed for Anal Itching, Atopic Dermatitis, Dermatitis, Cutaneous T-cell Lymphoma, Psoriasis, Dermatological Disorders, Eczema, Lichen Planopilaris, Lichen Planus, Lichen Sclerosus, Necrobiosis... View more |
Related suggestions Popular comparisons
|
|||||||
More about Acitretin | More about Apremilast | More about Clobetasol topical | ||||||||
Ratings & Reviews | ||||||||||
Acitretin has an average rating of 5.5 out of 10 from a total of 35 ratings on Drugs.com. 41% of reviewers reported a positive effect, while 37% reported a negative effect. |
Apremilast has an average rating of 5.2 out of 10 from a total of 467 ratings on Drugs.com. 36% of reviewers reported a positive effect, while 40% reported a negative effect. |
Clobetasol topical has an average rating of 8.3 out of 10 from a total of 161 ratings on Drugs.com. 79% of reviewers reported a positive effect, while 13% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
Generic Availability | ||||||||||
Lower cost generic |
N/A |
Lower cost generic |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
View all Acitretin prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms Available | ||||||||||
|
N/A |
|
||||||||
Brand Names | ||||||||||
Soriatane | Otezla | Clobevate, Clobex, Clodan, Cormax, Cormax Scalp, Dermovate, Embeline, Embeline E, Impeklo, Impoyz, Olux, Olux-E, Temovate, Temovate Emollient, Tovet View more | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
96 hours |
9 hours |
N/A |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 67 drugs are known to interact with Acitretin:
|
A total of 101 drugs are known to interact with Apremilast:
|
A total of 48 drugs are known to interact with Clobetasol topical:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
October 28, 1996 |
March 21, 2014 |
December 27, 1985 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.